ClinVar Miner

Submissions for variant NM_004247.4(EFTUD2):c.105+2T>G

dbSNP: rs2051339634
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001266947 SCV001445128 likely pathogenic Inborn genetic diseases 2019-03-11 criteria provided, single submitter clinical testing The alteration is predicted to abolish the native donor splice site: The c.105+2T>G alteration is in intron 2 of the EFTUD2 gene and results from a T to G substitution at nucleotide position 105+2. Alterations that disrupt the canonical splice donor site are typically deleterious in nature (Richards, 2015). The alteration is not observed in population databases: Based on data from the Genome Aggregation Database (gnomAD), the EFTUD2 c.105+2T>G alteration was not observed, with coverage at this position. The altered nucleotide is conserved throughout evolution: The c.105+2T nucleotide is conserved in available vertebrate species. The alteration is predicted to affect splicing by in silico models: Based on BDGP and ESEfinder splice site in silico tools, this alteration is predicted to abolish the native splice donor site; however, direct evidence is unavailable. Based on the available evidence, this alteration is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.